Institutional shares held 1.68 Billion
17.6M calls
14.5M puts
Total value of holdings $260B
$2.74B calls
$2.25B puts
Market Cap $406B
2,614,479,872 Shares Out.
Institutional ownership 64.2%
# of Institutions 4,271


Latest Institutional Activity in JNJ

Top Purchases

Q3 2024
Jpmorgan Chase & CO Shares Held: 33.8M ($5.24B)
Q3 2024
International Assets Investment Management, LLC Shares Held: 3.45M ($536M)
Q3 2024
Morgan Stanley Shares Held: 45.2M ($7.01B)
Q3 2024
Goldman Sachs Group Inc Shares Held: 13.4M ($2.08B)
Q3 2024
Janus Henderson Group PLC Shares Held: 3.39M ($526M)

Top Sells

Q3 2024
Bridgewater Associates, LP Shares Held: 1.47M ($228M)
Q3 2024
Ubs Asset Management Americas Inc Shares Held: 16.6M ($2.57B)
Q3 2024
Bristol John W & CO Inc Shares Held: 522K ($81.1M)
Q3 2024
Millennium Management LLC Shares Held: 81.4K ($12.6M)
Q3 2024
Northern Trust Corp Shares Held: 27.4M ($4.26B)

About JNJ

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.


Insider Transactions at JNJ

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
519K Shares
From 14 Insiders
Exercise of conversion of derivative security 449K shares
Bona fide gift 68.8K shares
Grant, award, or other acquisition 790 shares
Sell / Disposition
367K Shares
From 16 Insiders
Payment of exercise price or tax liability 225K shares
Open market or private sale 73.9K shares
Bona fide gift 68.9K shares

Track Institutional and Insider Activities on JNJ

Follow JOHNSON & JOHNSON and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNJ shares.

Notify only if

Insider Trading

Get notified when an Johnson & Johnson insider buys or sells JNJ shares.

Notify only if

News

Receive news related to JOHNSON & JOHNSON

Track Activities on JNJ